Anbc, Inc. (SYUP)

OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
At close: Jun 27, 2025
-98.75%
Market Cap7.96K
Revenue (ttm)50.95K
Net Income (ttm)-382.25K
Shares Out79.60M
EPS (ttm)n/a
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume500
Average Volume33,895
Open0.0001
Previous Close0.0001
Day's Range0.0001 - 0.0001
52-Week Range0.0001 - 0.0050
Beta-5.71
RSI41.30
Earnings Daten/a

About Anbc, Inc.

Shanghai Yutong Pharma, Inc. engages in the development, manufacturing, and commercialization of traditional Chinese herbal medicines and biological pharmaceuticals in the People’s Republic of China. Its products primarily include Qilisheng a product formulated to be a general health enhancer by fortifying the immune system; Qi-ju-di-huang, an oral solution that protects the kidney and the liver; Qing-re-jie-du, an oral solution that reduces fever and relieves heat; Sheng-mai-yin, a solution that protects energy and enhances body fluids; Xiao-q... [Read more]

Sector Healthcare
CEO Wei Dong
Country United States
Stock Exchange OTCMKTS
Ticker Symbol SYUP
Full Company Profile

Financial Performance

In 2007, Anbc, Inc.'s revenue was $50,946, a decrease of -83.70% compared to the previous year's $312,494. Losses were -$382,246, 18.2% more than in 2006.

Financial Statements

News

There is no news available yet.